Baxter International Inc.

NYSE:BAX

Medical - Instruments & Supplies

Healthcare
$26.16 -5.23%

-$1.07 today

Market cap
$13.53B
Beta
0.64
P/E (TTM)
-9.1
EPS (TTM)
-$2.13
Dividend yield
1.03%
52W Low $15.73High $31.76

Volume 4.01M

Average 7.62M

BAX Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Baxter International Inc.NYSE: BAX

Stock-Based Compensation · Q2 FY2026 · quarter ended Jun 2026

Stock-based compensation declines year over year

Q2 FY2026 stock-based compensation of $33M fell 5.7% year over year, in line with the -5.7% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 230.0% from the prior quarter. Over 3 fiscal years it compounded at -5.8% a year.

Context

  • Stock-based compensation amounted to 1.0% of revenue in FY2025, unchanged from a year earlier.
  • Stock-based compensation increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -5.7% holds above the trailing-twelve-month pace of -5.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$33M+230.0% QoQ
Last fiscal yearDec 2025
$117M+2.6% YoY
LTMJun 2026
$115M-5.7% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-5.7%——
1 year+2.6%——
3-year CAGR-5.8%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
117M USD
Year-over-year change
+2.6%
4-year CAGR
-5.4%

Stock-Based Compensation vs competitors

How BAX compares with its peers on the latest reported figures

  • Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -5.7% is the 3rd highest of 5, against a peer median of -9.9%.
  • Stock-based compensation amounts to 1.0% of revenue for BAX, versus a peer median of 1.4%.
BAX Competitors
Stock-Based Compensation for BAX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DVADaVita Inc.LTM Jun 2026$131.58M USD+12.9%+13.6%0.9%
BAXBaxter International Inc.LTM Jun 2026$115M USD-5.7%-5.8%1.0%
ICUIICU Medical, Inc.LTM Jun 2026$41.12M USD-19.2%+15.7%1.9%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$4.49M USD-0.5%+4.5%3.2%
FMSFresenius Medical Care AG & Co. KGaALTM Jun 2026€0 EUR-100.0%—0.0%
Peer median (excluding BAX) —-9.9%+13.6%1.4%

Competitors are the stored peer set for BAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.03B(3.11B)181M(326M)(957M)
Depreciation & Amortization867M1.07B984M997M981M
Deferred Income Tax(161M)(260M)(256M)(262M)77M
Stock-Based Compensation146M140M115M114M117M
Change in Working Capital(57M)(606M)161M(236M)(108M)
Accounts Receivables(170M)(48M)(38M)(35M)(132M)
Inventory(27M)(198M)(128M)(201M)(119M)
Accounts Payables105M(67M)92M112M3M
Other Working Capital35M(293M)235M(112M)140M
Other Non-Cash Items394M3.98B541M732M735M
Operating Cash Flow2.22B1.21B1.73B1.02B845M
Capital Expenditures(691M)(635M)(436M)(460M)(522M)
Acquisitions (Net)(10.5B)(263M)(6M)00
Purchases of Investments00000
Sales of Investments00034M0
Other Investing Activities(7M)(33M)3.66B(200M)3.35B
Investing Cash Flow(11.2B)(931M)3.21B(626M)2.84B
Debt Repayment9.33B(899M)(2.94B)(531M)(3.79B)
Common Stock Issued187M127M95M71M30M
Common Stock Repurchased(600M)(32M)000
Dividends Paid(530M)(573M)(586M)(590M)(348M)
Other Financing Activities(138M)(61M)(63M)(31M)(107M)
Financing Cash Flow8.25B(1.44B)(3.49B)(1.08B)(4.22B)
Effect of Forex Changes(47M)(76M)26M(96M)84M
Net Change in Cash(780M)(1.23B)1.48B(784M)(446M)
Free Cash Flow1.53B576M1.29B559M323M

Baxter International Inc.

NYSE:BAX

Intrinsic Alpha fair value

Locked

Current Price

$26.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.